Memorial Sloan-Kettering is a comprehensive center for the detection and treatment of thyroid cancer. Over the past decade, our team has treated more than 6,000 people with thyroid cancer, one of the most curable types of cancer. Some key features of our approach to diagnosis and treatment include:
Our experts describe recent advances in the treatment of thyroid cancer and research on new therapeutic approaches.
- Our thyroid cancer experts use the latest surgical techniques, including minimally invasive approaches when possible.
- We were among the first to routinely use synthetic thyroid stimulating hormone (TSH) in combination with radioactive iodine therapy, improving both the effectiveness of the therapy and the quality of patients’ lives.
- Our radiologists are experts in Image Modulated Radiation Therapy (IMRT), which targets radiation treatments directly to tumors while sparing surrounding tissue.
- We use PET scans in patients with a high risk of tumor recurrence to determine whether the cancer is growing or has spread, and to select the most appropriate follow-up treatment.
- Memorial Sloan-Kettering researchers have also identified many of the genetic changes that can result in thyroid cancer, and are using this knowledge to develop a new generation of novel therapies.
We use a multidisciplinary approach to provide the best possible diagnosis and treatment for patients with thyroid cancer. Our treatment team, consisting of specialists from all disciplines involved in the treatment of thyroid cancer, meets weekly to review all patient cases. This ensures that you will receive the combination of therapies that will best address your individual condition.
Our doctors participate in most national clinical trials, as well as clinical trials initiated at Memorial Sloan-Kettering, to improve the detection and treatment of thyroid cancer. Our doctors also participate regularly in national and international medical meetings to present their research.